Encorafenib Interactions
There are 624 drugs known to interact with encorafenib, along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 277 are major, 337 are moderate, and 10 are minor.
- View all 624 medications that may interact with encorafenib
- View encorafenib alcohol/food interactions (1)
- View encorafenib disease interactions (5)
Most frequently checked interactions
View interaction reports for encorafenib and the medicines listed below.
- Ambien (zolpidem)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Benadryl (diphenhydramine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Compazine (prochlorperazine)
- Copper (copper gluconate)
- Coricidin HBP Cough & Cold (chlorpheniramine / dextromethorphan)
- Dexilant (dexlansoprazole)
- Dulcolax Stool Softener (docusate)
- Ecotrin Adult Low Strength (aspirin)
- Emla (lidocaine / prilocaine topical)
- Ethyl Alcohol (ethanol)
- Fentanyl Transdermal System (fentanyl)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Imodium (loperamide)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Lomotil (atropine / diphenoxylate)
- Minocin (minocycline)
- Neuriva Brain performance Plus (multivitamin)
- Opium Tincture, Deodorized (opium)
- Tramadol Hydrochloride ER (tramadol)
- Valproate Sodium (valproic acid)
- Vitamin D3 (cholecalciferol)
Encorafenib alcohol/food interactions
There is 1 alcohol/food interaction with encorafenib.
Encorafenib disease interactions
There are 5 disease interactions with encorafenib which include:
Report options
More about encorafenib
- encorafenib consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
